Physician profile
Rylan Chan
NPI 1306874623
$6,317.96
in general payments reported to CMS, 2019-2025
44 companies · $1,687 in 2025
The $1,687 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.56 · 2022: $952 · 2023: $1,656 · 2024: $2,007 · 2025: $1,687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,350.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $921.51 | 2022-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $654.95 | 2021-2025 | |
| Novo Nordisk INC | $571.64 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $571.28 | 2023-2025 | Repatha, Evenity, Prolia |
| Pfizer INC. | $510.97 | 2022-2025 | |
| Glaxosmithkline, LLC. | $338.76 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novartis Pharmaceuticals Corporation | $289.54 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $255.29 | 2022-2025 | |
| Lilly USA, LLC | $204.33 | 2022-2025 | Mounjaro, Jardiance, Emgality |
| Exact Sciences Corporation | $198.32 | 2023-2025 | Cologuard Collection Kit |
| Antares Pharma, INC. | $151.34 | 2022-2024 | Xyosted, Tlando, Nocdurna |
| Janssen Pharmaceuticals, INC | $146.36 | 2023-2025 | Spravato |
| Otsuka America Pharmaceutical, INC. | $138.97 | 2024-2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $120.32 | 2022-2024 | Xifaxan, Trulance |
| Idorsia Pharmaceuticals US INC | $108.41 | 2022-2024 | Quviviq |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rylan Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.